Diagnostic Pathology of Tumors of Peripheral Nerve.
Belakhoua SM, Rodriguez FJ.
Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021.
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
Miettinen MM, Antonescu CR, Fletcher CDM, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamimov A, Stewart DR, Viskochil D, Widemann B, Perry A.
Hum Pathol. 2017 Sep;67:1-10. doi: 10.1016/j.humpath.2017.05.010. Epub 2017 May 24.
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H, Xing C, Zhang J, He B.
Reprod Health. 2021 Aug 18;18(1):171. doi: 10.1186/s12978-021-01207-7.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
Odate T, Satomi K, Kubo T, Matsushita Y, Ueno T, Kurose A, Shomori K, Nakai T, Watanabe R, Segawa K, Ohshika S, Miyake N, Kudo S, Shimoi T, Kobayashi E, Komiyama M, Yoshimoto S, Nakatani F, Kawai A, Yatabe Y, Kohsaka S, Ichimura K, Ichikawa H, Yoshida A.
Mod Pathol. 2024 Jan;37(1):100359. doi: 10.1016/j.modpat.2023.100359. Epub 2023 Oct 21.
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.
Lucas CG, Gross AM, Romo CG, Dehner CA, Lazar AJ, Miettinen M, Pekmezci M, Quezado M, Rodriguez FJ, Stemmer-Rachamimov A, Viskochil D, Perry A; Symposium on Atypical Neurofibroma: State of the Science Members.
Neuro Oncol. 2025 Mar 7;27(3):616-624. doi: 10.1093/neuonc/noae235.
Cardiac tumors.
Petris AO, Alexandrescu DM, Costache II.
Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):289-92.
A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Lindor NM, Guidugli L, Wang X, Vallée MP, Monteiro AN, Tavtigian S, Goldgar DE, Couch FJ.
Hum Mutat. 2012 Jan;33(1):8-21. doi: 10.1002/humu.21627. Epub 2011 Nov 3.
Può la scienza post-normale applicarsi all’oncologia radioterapica? Le incertezze della scienza nelle conoscenze disciplinari.
Di Naro A, Portaluri M, Muni R, Motta M, Bambace S, Castelluccia A, Tramacere F, Sala M, Cesa S, De Marchi B.
Recenti Prog Med. 2024 Dec;115(12):616-617. doi: 10.1701/4392.43926.
PROGNOSIS uncertain.
[No authors listed]
Cancer Bull. 1953 Sep-Oct;5(5):99-101; passim.
